Predictive Factors of Stent Patency in Iliofemoral Venous Diseases in a Multicentre Cohort Study

医学 血栓后综合征 中止 外科 深静脉 血栓形成 支架
作者
O. Espitia,Frédéric Douane,Jeanne Hersant,Fabrice Abbadie,Jonathan Sobocinski,Jean-François Heautot,Annaïg Miossec,François-Xavier Lapébie,Olivier Hartung
出处
期刊:European Journal of Vascular and Endovascular Surgery [Elsevier BV]
卷期号:65 (4): 564-572 被引量:6
标识
DOI:10.1016/j.ejvs.2023.01.005
摘要

This study assessed primary stent patency predictive factors in three groups of patients with history of lower limb (LL) vein thrombosis: non-thrombotic iliac vein lesion (NIVL), acute deep vein thrombosis (aDVT), and post-thrombotic syndrome (PTS).Consecutive patients from January 2014 to December 2020 with history of LL vein stenting from seven hospitals were included. All patients received an iliac or common femoral venous stent and had at least a six month follow up available with stent imaging. Anticoagulant and antiplatelet therapy strategies employed after venous stenting are reported and compared between groups.This study included 377 patients: 134 NIVL, 55 aDVT, and 188 PTS. Primary patency was statistically significantly higher in the NIVL group (99.3%) compared with the PTS group (68.6%) (p < .001) and the aDVT group (83.6%) (p = .002). PTS patients received a statistically significantly greater number of stents (p < .001) and had more stents below the inguinal ligament (p < .001). Median follow up was 28.8 months (IQR 16, 47). Discontinuation of antiplatelet therapy at the last assessment was 83.6% for NIVL, 100% for aDVT, and 95.7% for the PTS group (p < .001). Discontinuation of anticoagulation therapy at the last assessment was 93.2% for NIVL, 25.0% for aDVT, and 70.3% for the PTS group (p < .001). The only predictor of worse primary patency in the aDVT group was long term anticoagulation before stenting.Patients with NIVL have better primary patency after venous stenting than patients with venous thrombotic disorders. Long term anticoagulation before stenting was the only factor associated with poorer primary patency in patients with aDVT.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
明芬完成签到,获得积分10
2秒前
3秒前
123456完成签到,获得积分10
6秒前
结实的慕凝完成签到,获得积分10
8秒前
苗条小土豆完成签到,获得积分10
8秒前
flance完成签到 ,获得积分10
10秒前
11秒前
fanfan完成签到 ,获得积分10
13秒前
SkyTsai完成签到,获得积分10
13秒前
16秒前
17秒前
轻松的惜芹应助诚心谷南采纳,获得10
17秒前
天天快乐应助sml采纳,获得10
18秒前
20秒前
21秒前
21秒前
华仔应助sxx采纳,获得10
24秒前
YJ888发布了新的文献求助10
25秒前
26秒前
哼哼唧唧发布了新的文献求助10
26秒前
石大大发布了新的文献求助10
28秒前
huoguo完成签到,获得积分10
29秒前
小二郎应助完美芒果采纳,获得10
29秒前
Liufgui应助紫竹魔笛采纳,获得10
31秒前
32秒前
34秒前
Liufgui应助YJ888采纳,获得10
35秒前
赘婿应助麦子采纳,获得10
35秒前
36秒前
KK发布了新的文献求助10
36秒前
娟姐完成签到,获得积分10
37秒前
ding应助李朝富采纳,获得10
38秒前
桐桐应助学术蝗虫采纳,获得10
39秒前
杨桃发布了新的文献求助10
39秒前
40秒前
biubiudididi发布了新的文献求助10
40秒前
YUMI发布了新的文献求助10
41秒前
科研通AI5应助slx采纳,获得10
41秒前
搜集达人应助娟姐采纳,获得10
43秒前
完美芒果发布了新的文献求助10
44秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989550
求助须知:如何正确求助?哪些是违规求助? 3531774
关于积分的说明 11254747
捐赠科研通 3270278
什么是DOI,文献DOI怎么找? 1804966
邀请新用户注册赠送积分活动 882125
科研通“疑难数据库(出版商)”最低求助积分说明 809176